Heartbeam Inc (BEAT) Stock Price, Quote & News

Company Profile

HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recordi...

Industry: Health Information Services

Sector: Healthcare

Phone: 408 899 4443

Website: www.heartbeam.com

Address:

2118 Walsh Avenue, Suite 210, Santa Clara, United States

TheRoost3r Aug. 3 at 2:12 PM

$BEAT Oh Lord .. this is painful to watch. I have no choice at this point but still hopeful for the second half of 2026

0 · Reply

BrightStars Aug. 3 at 2:08 PM

$BEAT Start distributing and get revenue in for the next FDA Approval/trial ….sell the product !!!!!

1 · Reply

BrightStars Aug. 3 at 2:07 PM

$BEAT I wish they would start commercially distributing.

0 · Reply

nhadar Aug. 2 at 6:41 PM

$BEAT lmg they’re gonna announce bankruptcy maybe in the meeting

1 · Reply

Pathtoretirement Aug. 2 at 12:34 AM

$BEAT We fucked unkess they have sales.

0 · Reply

BrightStars Aug. 1 at 6:13 PM

$BEAT I am not a fan of analysts but in this case I hope they are right and the price is $3+ very soon. Looking for great news in August.

1 · Reply

BrightStars Jul. 31 at 5:21 PM

$BEAT the only ones making money here is the board of directors. Ugh 😑

1 · Reply

millboy800 Jul. 31 at 5:10 PM

$BEAT well that wasn’t anything that I could write home about.

0 · Reply

Oil_Pal Jul. 31 at 4:26 PM

$BEAT 17- full time employees 31 team members Show us some substance you have other irons in the fire

0 · Reply

nhadar Jul. 31 at 2:34 PM

$BEAT you’re lucky they got a sucker the last sucker for the offering at $.80

0 · Reply

HeartBeam Transcript: AGM 2026

Jul 30, 2026, 7:00 AM EDT - 4 days ago

HeartBeam to Host Second Quarter 2026 Results Conference Call on Thursday, August 13, 2026 at 4:30 p.m. Eastern Time

2026-07-14T11:55:31.000Z - 20 days ago

HeartBeam initiated with a Buy at Maxim

2026-07-14T11:05:21.000Z - 20 days ago

HeartBeam awarded U.S. patent for ECG device capabilities

2026-06-30T11:05:24.000Z - 4 weeks ago

HeartBeam completes patient enrollment in ALIGN-ACS pilot study

Jun 30, 2026, 7:00 AM EDT - 4 weeks ago

HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule

Jun 25, 2026, 8:00 AM EDT - 5 weeks ago

HeartBeam Proxy statement: Proxy filing

2026-06-24T20:10:41.000Z - 5 weeks ago

HeartBeam announces strategic shift to ambulatory ECG signal platform

Jun 24, 2026, 4:05 PM EDT - 5 weeks ago

HeartBeam Announces Strategic Shift to Accelerate Global Adoption of its Ambulatory ECG Signal Platform and Leadership Transition

Jun 18, 2026, 8:00 AM EDT - 6 weeks ago

HeartBeam Proxy statement: Proxy filing

Jun 5, 2026, 8:00 AM EDT - 2 months ago

HeartBeam Proxy statement: Proxy filing

Jun 5, 2026, 7:00 AM EDT - 2 months ago

HeartBeam Slides: Investor presentation

2026-06-02T11:05:34.000Z - 2 months ago

HeartBeam announces peer-reviewed article in JACC on HeartBeam ECG

Jun 2, 2026, 7:00 AM EDT - 2 months ago

HeartBeam Announces New Peer-Reviewed Article Demonstrating Potential to Help Identify Heart Attack Risk at Home

2026-05-22T10:10:58.000Z - 2 months ago

HeartBeam price target lowered to $2.50 from $5.50 at H.C. Wainwright

2026-05-15T14:03:56.000Z - 2 months ago

HeartBeam price target lowered to $5 from $8 at Benchmark

May 13, 2026, 4:30 PM EDT - 2 months ago

HeartBeam Earnings Call Transcript: Q1 2026

May 13, 2026, 4:30 PM EDT - 2 months ago

HeartBeam Quarterly report: Q1 2026

May 13, 2026, 4:30 PM EDT - 2 months ago

HeartBeam Slides: Q1 2026

May 13, 2026, 4:30 PM EDT - 2 months ago

HeartBeam Earnings release: Q1 2026

2026-05-13T20:08:51.000Z - 2 months ago

HeartBeam reports Q1 EPS (12c) vs. (18c) last year

May 13, 2026, 4:01 PM EDT - 2 months ago

HeartBeam Reports First Quarter 2026 Results

2026-05-11T15:12:35.000Z - 2 months ago

HeartBeam initiates pilot study of first on-demand 12-lead ECG patch

May 11, 2026, 8:31 AM EDT - 3 months ago

HeartBeam Initiates Pilot Study of First On-Demand 12-Lead ECG Patch to Detect Ischemia Outside the Clinic

2026-05-07T20:27:33.000Z - 3 months ago

HeartBeam announces commercial agreement with Atelier Health

May 7, 2026, 8:31 AM EDT - 3 months ago

HeartBeam Expands Commercial Presence Across Four Key U.S. Markets with Addition of Premier Concierge Practice

Apr 30, 2026, 8:31 AM EDT - 3 months ago

HeartBeam to Host First Quarter 2026 Results Conference Call on Wednesday, May 13, 2026 at 4:30 p.m. Eastern Time

2026-04-20T12:02:38.000Z - 3 months ago

HeartBeam downgraded to Hold from Buy at D. Boral Capital

Apr 16, 2026, 4:05 PM EDT - 3 months ago

HeartBeam Announces Closing of $10 Million Public Offering of Common Stock

Apr 16, 2026, 7:00 AM EDT - 3 months ago

HeartBeam Slides: Investor presentation

2026-04-15T09:55:54.000Z - 3 months ago

HeartBeam 12.5M share Spot Secondary priced at 80c

Apr 14, 2026, 10:00 PM EDT - 3 months ago

HeartBeam Announces Pricing of $10 Million Public Offering of Common Stock

2026-04-14T20:10:16.000Z - 3 months ago

HeartBeam announces common stock offering, no amount given

Apr 14, 2026, 4:05 PM EDT - 3 months ago

HeartBeam Announces Proposed Public Offering of Common Stock

2026-03-31T09:40:38.000Z - 4 months ago

HeartBeam initiated with a Buy at B. Riley

2026-03-31T09:20:14.000Z - 4 months ago

HeartBeam initiated with a Buy at Stifel

2026-03-27T12:37:18.000Z - 4 months ago

HeartBeam initiated with a Buy at D. Boral Capital

Mar 16, 2026, 11:20 AM EDT - 4 months ago

HeartBeam Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Mar 13, 2026, 8:00 AM EDT - 5 months ago

HeartBeam Registration statement: Registration Filing

Mar 12, 2026, 4:30 PM EDT - 5 months ago

HeartBeam Earnings Call Transcript: Q4 2025

Mar 12, 2026, 4:30 PM EDT - 5 months ago

HeartBeam Earnings release: Q4 2025

Mar 12, 2026, 4:30 PM EDT - 5 months ago

HeartBeam Annual report: Q4 2025

Mar 12, 2026, 4:30 PM EDT - 5 months ago

HeartBeam Slides: Q4 2025

2026-03-12T20:05:25.000Z - 5 months ago

HeartBeam reports Q4 EPS (62c) vs (73c) last year

Mar 12, 2026, 4:01 PM EDT - 5 months ago

HeartBeam Reports Fourth Quarter and Full Year 2025 Results

Mar 12, 2026, 7:00 AM EDT - 5 months ago

HeartBeam Slides: Investor presentation

2026-03-10T11:27:46.000Z - 5 months ago

HeartBeam announces AI pact with Icahn School of Medicine at Mount Sinai

Mar 10, 2026, 7:00 AM EDT - 5 months ago

HeartBeam and Mount Sinai Announce Strategic AI Collaboration to Bring Clinical-Grade Heart Monitoring into the Home

Mar 9, 2026, 7:00 AM EDT - 5 months ago

HeartBeam to Attend Investor and Industry Conferences in March, Focused on Providing Updates on Commercial Launch and Unveiling 12-Lead ECG Extended Wear Patch

2026-03-05T12:22:48.000Z - 5 months ago

HeartBeam enrolls first patients in ALIGN-ACS pilot study

Mar 5, 2026, 7:00 AM EST - 5 months ago

HeartBeam Announces First Patient Enrollments in Heart Attack Detection Pilot Study

Mar 4, 2026, 4:01 PM EST - 5 months ago

HeartBeam to Host Fourth Quarter Full Year 2025 Results Conference Call on Thursday, March 12, 2026 at 4:30 p.m. Eastern Time

2026-03-04T13:38:09.000Z - 5 months ago

HeartBeam announces investment from, partnership with ClearCardio

Mar 4, 2026, 7:00 AM EST - 5 months ago

HeartBeam Announces First Commercial Customer as ClearCardio Brings Groundbreaking 12-Lead ECG Technology to High-Growth Preventive Cardiology Market

Feb 9, 2026, 7:00 AM EST - 6 months ago

HeartBeam Registration statement: Registration Filing

Jan 22, 2026, 7:00 AM EST - 6 months ago

HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer

Jan 5, 2026, 7:00 AM EST - 7 months ago

HeartBeam to Attend JP Morgan 2026 Annual Healthcare Conference

Dec 10, 2025, 7:00 AM EST - 8 months ago

HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment

Nov 26, 2025, 4:32 PM EST - 8 months ago

HeartBeam Provides Update on Regulatory Path Following FDA Decision on 12-Lead ECG Synthesis Software Application

Nov 13, 2025, 4:30 PM EST - 9 months ago

HeartBeam Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:30 PM EST - 9 months ago

HeartBeam Earnings release: Q3 2025

Nov 13, 2025, 4:30 PM EST - 9 months ago

HeartBeam Quarterly report: Q3 2025

Nov 13, 2025, 4:30 PM EST - 9 months ago

HeartBeam Slides: Q3 2025

Nov 13, 2025, 4:01 PM EST - 9 months ago

HeartBeam Reports Third Quarter 2025 Results

Oct 30, 2025, 7:00 AM EDT - 9 months ago

HeartBeam to Host Third Quarter 2025 Results Conference Call on Thursday, November 13, 2025 at 4:30 p.m. Eastern Time

Oct 28, 2025, 7:00 AM EDT - 9 months ago

HeartBeam Teams Up With HeartNexus to Deliver Cardiologist-Level ECG Insights Anytime, Anywhere

Sep 8, 2025, 7:00 AM EDT - 11 months ago

HeartBeam's Deep Learning Algorithms Demonstrate High Rates of Accuracy for Detecting Arrhythmias

Aug 28, 2025, 7:00 AM EDT - 1 year ago

HeartBeam to Participate at Upcoming Industry and Investor Conferences, September 4-10, 2025

Aug 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Earnings Call Transcript: Q2 2025

Aug 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Earnings release: Q2 2025

Aug 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Quarterly report: Q2 2025

Aug 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Slides: Q2 2025

Aug 13, 2025, 4:01 PM EDT - 1 year ago

HeartBeam Reports Second Quarter 2025 Results

Jul 30, 2025, 7:00 AM EDT - 1 year ago

HeartBeam to Host Second Quarter 2025 Results Conference Call on Wednesday, August 13, 2025 at 4:30 p.m. Eastern Time

Jul 22, 2025, 7:00 AM EDT - 1 year ago

HeartBeam Wins Industry Innovation Award for Advancing Remote Cardiac Care With Groundbreaking ECG Technology

Jun 24, 2025, 2:00 PM EDT - 1 year ago

HeartBeam Transcript: IAccess Alpha Virtual Best Ideas Summer Investment Conference 2025

Jun 17, 2025, 7:00 AM EDT - 1 year ago

HeartBeam to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24, 2025

May 29, 2025, 8:00 AM EDT - 1 year ago

HeartBeam Proxy statement: Proxy Filing

May 19, 2025, 8:00 AM EDT - 1 year ago

HeartBeam Proxy statement: Proxy Filing

May 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Earnings Call Transcript: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Earnings release: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Quarterly report: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Slides: Q1 2025

May 13, 2025, 4:01 PM EDT - 1 year ago

HeartBeam Reports First Quarter 2025 Results

May 6, 2025, 7:00 AM EDT - 1 year ago

HeartBeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio

May 5, 2025, 7:00 AM EDT - 1 year ago

HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth

May 1, 2025, 8:31 AM EDT - 1 year ago

HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time

Apr 29, 2025, 8:31 AM EDT - 1 year ago

HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology

Apr 24, 2025, 8:31 AM EDT - 1 year ago

HeartBeam and AccurKardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation

Mar 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Earnings Call Transcript: Q4 2024

Mar 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Annual report: Q4 2024

Mar 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Earnings release: Q4 2024

Mar 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Slides: Q4 2024

Mar 13, 2025, 4:01 PM EDT - 1 year ago

HeartBeam Reports Fourth Quarter and Full Year 2024 Results

Mar 6, 2025, 9:01 AM EST - 1 year ago

HeartBeam to Participate at Upcoming Conferences in Dana Point, California, March 16-21, 2025

Feb 27, 2025, 8:31 AM EST - 1 year ago

HeartBeam to Host Fourth Quarter Full Year 2024 Results Conference Call on Thursday, March 13, 2025 at 4:30 p.m. Eastern Time

Feb 25, 2025, 4:01 PM EST - 1 year ago

HeartBeam Announces Exercise and Closing of Underwriter's Over-Allotment Option for Public Offering of Common Stock

Feb 13, 2025, 8:31 AM EST - 1 year ago

HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock

Jan 29, 2025, 8:31 AM EST - 1 year ago

HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software

Dec 23, 2024, 8:31 AM EST - 1 year ago

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

Dec 16, 2024, 8:31 AM EST - 1 year ago

HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology

Nov 19, 2024, 8:31 AM EST - 1 year ago

HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference

Nov 7, 2024, 4:30 PM EST - 1 year ago

HeartBeam Earnings Call Transcript: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

HeartBeam Earnings release: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

HeartBeam Quarterly report: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

HeartBeam Slides: Q3 2024

Nov 7, 2024, 4:05 PM EST - 1 year ago

HeartBeam Reports Third Quarter 2024 Results

Oct 31, 2024, 8:31 AM EDT - 1 year ago

HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time

Oct 24, 2024, 8:31 AM EDT - 1 year ago

HeartBeam Named “Rising Star” at the 6th Annual Digital Health Hub Foundation Awards

Oct 17, 2024, 8:31 AM EDT - 1 year ago

HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization

Sep 24, 2024, 8:31 AM EDT - 2 years ago

HeartBeam Appoints Dr. Lance Myers as Chief AI Scientist

TheRoost3r Aug. 3 at 2:12 PM

$BEAT Oh Lord .. this is painful to watch. I have no choice at this point but still hopeful for the second half of 2026

0 · Reply

BrightStars Aug. 3 at 2:08 PM

$BEAT Start distributing and get revenue in for the next FDA Approval/trial ….sell the product !!!!!

1 · Reply

BrightStars Aug. 3 at 2:07 PM

$BEAT I wish they would start commercially distributing.

0 · Reply

nhadar Aug. 2 at 6:41 PM

$BEAT lmg they’re gonna announce bankruptcy maybe in the meeting

1 · Reply

Pathtoretirement Aug. 2 at 12:34 AM

$BEAT We fucked unkess they have sales.

0 · Reply

BrightStars Aug. 1 at 6:13 PM

$BEAT I am not a fan of analysts but in this case I hope they are right and the price is $3+ very soon. Looking for great news in August.

1 · Reply

BrightStars Jul. 31 at 5:21 PM

$BEAT the only ones making money here is the board of directors. Ugh 😑

1 · Reply

millboy800 Jul. 31 at 5:10 PM

$BEAT well that wasn’t anything that I could write home about.

0 · Reply

Oil_Pal Jul. 31 at 4:26 PM

$BEAT 17- full time employees 31 team members Show us some substance you have other irons in the fire

0 · Reply

nhadar Jul. 31 at 2:34 PM

$BEAT you’re lucky they got a sucker the last sucker for the offering at $.80

0 · Reply

nhadar Jul. 31 at 2:07 PM

$BEAT atl sucks bankruptcy is the end game

1 · Reply

BrightStars Jul. 31 at 1:46 PM

$BEAT 9k in volume….if this product ever starts selling im going to have to buy it cuz …. Im dying’ here !

0 · Reply

millboy800 Jul. 30 at 6:57 PM

$BEAT reminder… there is a vote taking place. It’s at the Heartbeam site to log into the meeting. We need to be sure to vote. On what? I have no idea. Anyone?

4 · Reply

fiat1234 Jul. 30 at 5:30 PM

$BEAT 195 nations on earth,management better find somebody interested in their technology. Mark Hamburger claims to have done miracles with other companies, let's see if he can convince at least one country to use.

0 · Reply

Flyhai Jul. 30 at 3:47 PM

$BEAT been quiet lately

0 · Reply

SebNo1234 Jul. 30 at 12:31 PM

$BEAT We will never see $1 or more again. Nothing is happening here; the party is over.

1 · Reply

thecryptofire Jul. 30 at 9:53 AM

$BTC $XRP $ETH $KAITO $BEAT Discover how the Fed’s rate hold affected Bitcoin, crypto liquidations, gold, stocks, and oil—and which signals could drive the next market move. https://www.thecryptofire.com/p/fed-interest-rates-and-bitcoin-what-the-latest-decision-means

0 · Reply

gapureau Jul. 29 at 1:37 PM

$BEAT Been watching, trading, and holding shares since the IPO. Have talked with management and last year I warned them the $1 minimum bid rule was going to be a big issue as Investors are not interested in holding when a Reverse Split seems to be on the table. So here we are: There is some good news. Due to Recent NASDAQ rule change about 175+ companies (Many in medical research/development) are about to get De-Listing letters. Not due to Minimum Bid but Market Value being too low. Many stocks Day traders like to trade are going to be De-listed so maybe we will see more trading in $BEAT https://www.lucbro.com/news/sec-approves-nasdaqs-5-million-market-value-continued-listing-standard/

0 · Reply

Pathtoretirement Jul. 29 at 11:35 AM

$BEAT Next growth phase for AI stocks is in health care according to Zachs. One could only hope it includes Beat like the article says.

0 · Reply

BrightStars Jul. 28 at 2:47 PM

$BEAT somehow I think this could look like $VXRT soon. Remember them? I did make serious cash off of them and $NVAX back in days of world desiccation…but now they are flatlining. Someone posted .. this is crap until it isn’t. I agree. As long as BEAT doesn’t do a reverse split we have a chance … In a year ? Or..? Will it pop to $2,$3,$4 ? Ugh 😑

0 · Reply

BrightStars Jul. 28 at 12:48 PM

$BEAT so management is going to wait to spring the news at a conference sometime between September and November and then at the end of that day pop another 3M public offering. Will this even ‘pop’. ? We are DEAD ! Damn it ! Soooo FK’d

1 · Reply

BrightStars Jul. 27 at 10:47 PM

$BEAT how about some news of some new FDA trials starting !!!! Come on ! Pump it up. What’s the stalling ? Has anyone filed the paperwork? LFG !

0 · Reply

Market Cap	27.79M
Revenue (ttm)	0.00
Net Income (ttm)	-21.02M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	364,800
Avg Vol	788,528
Day's Range	N/A - N/A
Shares Out	55.51M
Stochastic %K	6%
Beta	-0.82
Analysts	Strong Sell
Price Target	$3.38